Britannia Life Sciences, Inc.

Market Cap: Micro Cap
Industry: Other Agricultural Products
ISIN: CA11042D1087

CAD

0.09

0.03 (41.67%)

May 06

CNQ

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Auxly Cannabis Group, Inc.

Inter-Rock Minerals, Inc.

StateHouse Holdings, Inc.

Burcon NutraScience Corp.

Optimi Health Corp.

Mountain Valley MD Holdings, Inc.

Britannia Life Sciences, Inc.

Global Hemp Group, Inc.

Heritage Cannabis Holdings Corp.

Body & Mind, Inc.

Cansortium, Inc.

Why is Britannia Life Sciences, Inc. ?

The company has declared Negative results for the last 4 consecutive quarters

NET PROFIT(Q) At CAD -0.14 MM has Fallen at -203.69%
OPERATING CASH FLOW(Y) Lowest at CAD 1.11 MM
ROCE(HY) Lowest at -175.45%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 60.00%, its profits have fallen by -797%

Real-Time Research Report

Verdict Report

No Data Found

Is Britannia Life Sciences, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Britannia Life Sciences, Inc.

-100.0%

0.15

221.71%

S&P/TSX 60

31.64%

1.43

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.81%

EBIT Growth (5y)

10.97%

EBIT to Interest (avg)

-1.39

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

4.92

Sales to Capital Employed (avg)

0.48

Tax Ratio

3.51%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.09%

ROE (avg)

4.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.89

EV to EBIT

0.21

EV to EBITDA

0.21

EV to Capital Employed

-0.23

EV to Sales

-0.34

PEG Ratio

0.01

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

60.73%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-1What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 87.79% (YoY

Here's what is not working for Britannia Life Sciences, Inc.

Raw Material Cost

Grown by 87.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales